Characteristics and Determinants of Patients Discontinuation of Breast Cancer Follow-Up Care at the Radiation Oncology Department, University College Hospital, Ibadan, Nigeria

Table 2

Clinical characteristics of breast cancer patients seen at UCH, Ibadan, 2001-2010.

Variable	Frequency ()
Site of disease
Right	227 (45.0%)
Left	244 (48.4%)
Bilateral	33 (6.5%)
Stage of disease (Manchester staging)
I	29 (5.8%)
II	177 (35.1%)
III	138 (27.4%)
IV	155 (30.8%)
Unknown	5 (1.0%)
Lymph node status
No axillary nodes	62 (12.3%)
Nodes limited to ipsilateral axilla	334 (66.3%)
Nodes beyond ipsilateral axilla	84 (16.7%)
Unknown	24 (4.8%)
Histological type
Invasive ductal carcinoma	443 (87.9%)
Invasive lobular carcinoma	23 (4.6%)
Inflammatory breast cancer	10 (2.0%)
Breast sarcoma	2 (0.2%)
Anaplastic carcinoma	3 (0.6%)
Malignant cystosarcoma phylloides	4 (0.8%)
Mucinous carcinoma	5 (1.0%)
Squamous cell carcinoma	4 (0.8%)
Paget's disease	2 (0.2%)
Others	8 (1.6%)
Histological grade
I	89 (17.7%)
II	303 (60.1%)
III	84 (16.7%)
Unknown	28 (5.6%)
Surgery
No surgery	34 (6.7%)
Radical surgery	413 (81.9%)
Breast conservation surgery	57 (11.3%)
Completed chemotherapy
Yes	498 (98.8%)
No	6 (1.2%)
Completed radiotherapy
Yes	493 (97.8%)
No	11 (2.2%)
Completed hormonal therapy
Yes	236 (46.8%)
No	268 (53.2%)
Developed metastasis
Yes	202 (40.1%)
No	302 (59.9%)
Sites of metastasis
Lungs	104 (20.6%)
Bone	116 (23.0%)
Liver	40 (7.9%)
Brain	26 (5.2%)
Kidney	1 (0.2%)
Baseline packed cell volume (PCV)
Low (PCV < 33%)	194 (38.5%)
Normal (PCV ≥ 33%)	310 (61.5%)